<DOC>
	<DOCNO>NCT01066728</DOCNO>
	<brief_summary>The objective present propose study discover whether , nursery set , administration low concentration inhale CO2 ( 0.8 % ) prolong period ( 3 day ) make breathe regular le apneic time observe administration theophylline . The hypothesis test inhalation low concentration CO2 ( 0.8 % ) reduce apnea effectively few adverse side effect theophylline .</brief_summary>
	<brief_title>CO2 Inhalation New Treatment Modality Apnea Prematurity</brief_title>
	<detailed_description>1 . To discover whether , nursery set , continuous administration low concentration inhale CO2 ( 0.8 % ) prolong period ( 3 day ) make breathe preterm infant regular less apneic time observed theophylline . 2 . To discover whether inhalation low CO2 decrease apneas , particularly prolong apnea ( &gt; 20 second ) , effectively theophylline . 3 . To discover whether short term ( hospitalization ) long term ( 2 year ) adverse side effect less pronounced CO2 theophylline .</detailed_description>
	<mesh_term>Apnea</mesh_term>
	<mesh_term>Premature Birth</mesh_term>
	<mesh_term>Theophylline</mesh_term>
	<criteria>Infants 27 32 week gestational age hospitalize neonatal intensive intermediate care unit Significant apnea , define 5 selfresolved apnea , 2 apnea require intervention 12 hr period Already methylxanthine treatment On supplemental oxygen , nasal continuous positive airway pressure ( CPAP ) Had major congenital anomaly , sepsis , know cause apnea</criteria>
	<gender>All</gender>
	<minimum_age>27 Weeks</minimum_age>
	<maximum_age>32 Weeks</maximum_age>
	<verification_date>January 2010</verification_date>
	<keyword>apnea</keyword>
	<keyword>premature</keyword>
	<keyword>infant</keyword>
	<keyword>prematurity</keyword>
</DOC>